Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure

被引:41
作者
Ye, Jing [1 ,2 ]
Wang, Zhen [1 ]
Ye, Di [1 ]
Wang, Yuan [1 ]
Wang, Menglong [1 ]
Ji, Qingwei [2 ]
Huang, Ying [2 ]
Liu, Ling [2 ]
Shi, Ying [2 ]
Shi, Lei [2 ]
Zeng, Tao [2 ]
Xu, Yao [1 ]
Liu, Jianfang [1 ]
Jiang, Huimin [1 ]
Lin, Yingzhong [1 ,2 ]
Wan, Jun [1 ]
机构
[1] Wuhan Univ, Hubei Key Lab Cardiol, Cardiovasc Res Inst, Dept Cardiol,Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
[2] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Cardiol, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
IL-11; TARGET; EXPRESSION; GALECTIN-3; BIOMARKERS; FIBROSIS; TH1/TH2;
D O I
10.1155/2019/1575410
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background. Interleukin-11 (IL-11) is an important inflammatory cytokine and has been demonstrated to participate in cardiovascular diseases. However, there have been no studies about the role of IL-11 in heart failure (HF). The present study is aimed at investigating whether IL-11 levels are associated with the cardiac prognosis in patients with HF. Methods. The plasma concentrations of IL-11 were measured in 240 patients with chronic HF (CHF) and 80 control subjects without signs of significant heart disease. In addition, we prospectively followed these CHF patients to endpoints of cardiac events. Results. Compared with the control group, the plasma IL-11 concentrations were significantly increased in the CHF patients and gradually increased in the New York Heart Association (NYHA) functional class II group, the NYHA functional class III group, and the NYHA functional class IV group. The receiver operating characteristic (ROC) curve revealed that the predictive role of IL-11 in HF is not as good as N-terminal B-type natriuretic peptide (BNP), although IL-11 has a certain value in predicting cardiac events. In addition, the CHF patients were divided into 3 groups according to the plasma IL-11 concentration category (low, T1; middle, T2; and high, T3). The multivariate Cox hazard analysis showed that the high plasma IL-11 concentrations were independently associated with the presence of cardiac events after adjustment for confounding factors. Furthermore, the CHF patients were divided into two groups based on the median plasma IL-11 concentrations. The Kaplan-Meier analysis revealed that the patients with high IL-11 concentrations had a higher risk of cardiac events compared with those with low IL-11 concentrations. Conclusions. Higher plasma IL-11 levels significantly increase the presence of cardiac events and suggest a poor outcome; although the diagnostic value of IL-11 in CHF is not as good as BNP, there is a certain value in predicting cardiac events in CHF.
引用
收藏
页数:8
相关论文
共 36 条
[1]   Study on the effect and mechanism of the dysfunction of CD4+ T cells in the disease process of chronic cardiac failure [J].
Cai, Yin-Hao ;
Ma, Zi-Jian ;
Lu, Xiu-Ying ;
He, En-Le ;
You, Ming-Yao .
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2016, 9 (07) :672-677
[2]   Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure [J].
Cappuzzello, Claudia ;
Di Vito, Luca ;
Melchionna, Roberta ;
Melillo, Guido ;
Silvestri, Lorena ;
Cesareo, Eleonora ;
Crea, Filippo ;
Liuzzo, Giovanna ;
Facchiano, Antonio ;
Capogrossi, Maurizio C. ;
Napolitano, Monica .
JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
[3]   Atorvastatin Modulates Th1/Th2 Response in Patients With Chronic Heart Failure [J].
Cheng, Xiang ;
Ding, Yingjun ;
Xia, Chunyan ;
Tang, Tingting ;
Yu, Xian ;
Xie, Jiangjiao ;
Liao, Mengyang ;
Yao, Rui ;
Chen, Yong ;
Wang, Min ;
Liao, Yu-Hua .
JOURNAL OF CARDIAC FAILURE, 2009, 15 (02) :158-162
[4]   Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association [J].
Chow, Sheryl L. ;
Maisel, Alan S. ;
Anand, Inder ;
Bozkurt, Biykem ;
de Boer, Rudolf A. ;
Felker, G. Michael ;
Fonarow, Gregg C. ;
Greenberg, Barry ;
Januzzi, James L., Jr. ;
Kiernan, Michael S. ;
Liu, Peter P. ;
Wang, Thomas J. ;
Yancy, Clyde W. ;
Zile, Michael R. .
CIRCULATION, 2017, 135 (22) :E1054-E1091
[5]   Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart [J].
Creemers, Esther E. ;
Pinto, Yigal M. .
CARDIOVASCULAR RESEARCH, 2011, 89 (02) :265-272
[6]   Galectin-3: A Modifiable Risk Factor in Heart Failure [J].
de Boer, Rudolf A. ;
van der Velde, A. Rogier ;
Mueller, Christian ;
van Veldhuisen, Dirk J. ;
Anker, Stefan D. ;
Peacock, W. Frank ;
Adams, Kirkwood F. ;
Maisel, Alan .
CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (03) :237-246
[7]   Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis [J].
Du, XX ;
Liu, Q ;
Yang, ZX ;
Orazi, A ;
Rescorla, FJ ;
Grosfeld, JL ;
Williams, DA .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 272 (03) :G545-G552
[8]   Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure [J].
Eiken, HG ;
Oie, E ;
Damås, JK ;
Yndestad, A ;
Bjerkeli, V ;
Aass, H ;
Simonsen, S ;
Geiran, OR ;
Tonnessen, T ;
Christensen, G ;
Froland, SS ;
Gullestad, L ;
Attramadal, H ;
Aukrust, P .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (05) :389-397
[9]   Is interleukin-22 a possible indicator of chronic heart failure's progression? [J].
Gangemi, S. ;
Parisi, P. ;
Ricciardi, L. ;
Saitta, S. ;
Minciullo, P. L. ;
Cristani, M. T. ;
Nicita-Mauro, V. ;
Saija, A. ;
Basile, G. .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2010, 50 (03) :311-314
[10]   Cardiac remodeling at the population level -risk factors, screening, and outcomes [J].
Gjesdal, Ola ;
Bluemke, David A. ;
Lima, Joao A. .
NATURE REVIEWS CARDIOLOGY, 2011, 8 (12) :673-685